Kuehn Law encourages Akero Therapeutics, Inc. investors. to contact the law firm through Investing.com
New York, New York–(Newsfile Corp. – December 30, 2024) – Kuehn Law, PLLC, a shareholder law firm, is investigating whether certain officers and directors Akero Therapeutics, Inc. (NASDAQ: NASDAQ:) breached their fiduciary duties to shareholders. The investigation is about potential self-dealing. Shareholders may be entitled to compensation and corporate governance reforms.
If you are long term AKRO shareholder contact Justin Kuehn, Esq. here, email justin@kuehn.law or call (833) 672-0814. Consultations and the case are free and do not oblige you. Kuehn Law pays all costs of the proceedings and does not charge its investor clients. Shareholders should contact the Company immediately as there may be a limited time to exercise your rights.
Why your participation is important:
As a shareholder, your voice is important, and by getting involved you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
For additional information, visit Shareholder Derivative Litigation – Kuehn Law.
Advertising of lawyers. Previous results do not guarantee similar results.
To view the original version of this press release, visit https://www.newsfilecorp.com/release/235602
